RT Journal Article SR Electronic T1 Close-range exposure to a COVID-19 carrier: transmission trends in the respiratory tract and estimation of infectious dose JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.07.27.20162362 DO 10.1101/2020.07.27.20162362 A1 Saikat Basu YR 2020 UL http://medrxiv.org/content/early/2020/07/29/2020.07.27.20162362.abstract AB How respiratory physiology and airflow therein proceed to impact SARS-CoV-2 transmission, leading to the initial infection, is an open question. An answer can help determine the susceptibility of an individual on exposure to a COVID-2019 carrier and can also quantify the still-unknown infectious dose for the disease. Combining computational fluid mechanics-based tracking of respiratory transport in anatomic domains with sputum assessment data from hospitalized patients and earlier measurements of ejecta size distribution during regular speech โ€“ this study shows that targeted deposition at the initial nasopharyngeal infection sites peaks over the droplet size range of 2.5 โ€“ 19 ยต, and reveals that the number of virions that can establish the infection is at most of ๐’ช (102).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis material is based upon work supported by the National Science Foundation (NSF), under Award Number 2028069 for COVID-19 research. Any opinions, findings, and conclusions or recommendations expressed here are those of the author and do not necessarily reflect NSF's views. Supplemental support came from SB's faculty start-up package at SDSU.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board at the University of North Carolina at Chapel HillAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis project has generated simulated quantitative, de-identified data on regional deposition along nasal tissues. The data-sets (including Fluent .cas, .dat files) and the numeric protocols; along with MATLAB codes, Wolfram Mathematica notebooks, and Microsoft Excel spreadsheets used for data post-processing - are available from the corresponding author on request, through a shared-domain Google Drive folder (see the reference list). https://drive.google.com/drive/folders/1OnEo_fPtSzIqG5_VLKpsg3L5ixG108cI?usp=sharing